Aperio Group’s Covetrus, Inc. Common Stock CVET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q4
$2.18M Sell
75,873
-1,141
-1% -$30.8K 0.01% 1195
2020
Q3
$1.88M Sell
77,014
-1,122
-1% -$24.2K 0.01% 1150
2020
Q2
$1.4M Sell
78,136
-3,846
-5% -$50.6K 0.01% 1260
2020
Q1
$668K Sell
81,982
-16,273
-17% -$186K ﹤0.01% 1494
2019
Q4
$1.3M Buy
98,255
+74,671
+317% +$904K ﹤0.01% 1298
2019
Q3
$281K Buy
23,584
+4,309
+22% +$79.8K ﹤0.01% 2048
2019
Q2
$472K Sell
19,275
-6,593
-25% -$190K ﹤0.01% 1813
2019
Q1
$824K Buy
+25,868
New +$918K ﹤0.01% 1459

Other funds holding CVET

Aperio Group's CVET Position: Q4 2020 in Review

Aperio Group reduced its Covetrus, Inc. Common Stock (CVET) stake by 1.5% in Q4 2020, selling an estimated $30.8K and leaving 75,873 shares worth $2.18M. The position accounts for 0.01% of the portfolio, ranked #1195.

Aperio Group first reported a position in CVET in Q1 2019 and has held it in 8 quarters since. 277 funds tracked by Wall St. Rank hold CVET as of Q4 2020.

  • Aperio Group held 75,873 shares of Covetrus, Inc. Common Stock worth $2.18M as of Q4 2020.
  • Aperio Group sold 1,141 Covetrus, Inc. Common Stock shares in Q4 2020, an estimated $30.8K.
  • Covetrus, Inc. Common Stock made up 0.01% of Aperio Group's portfolio in Q4 2020, its #1195 holding.
  • Aperio Group first reported a position in Covetrus, Inc. Common Stock in Q1 2019 and has held it in 8 quarters since.
  • 277 funds tracked by Wall St. Rank held Covetrus, Inc. Common Stock as of Q4 2020.

Based on Aperio Group's 13F filing for Q4 2020, filed 5 Feb 2021.